South Korea To Double Tamiflu Supply To Block Bird Flu
This article was originally published in PharmAsia News
South Korea plans to double its Tamiflu (oseltamivir phosphate) stockpile by the end of this year, giving it 2.5 million doses of Roche's bird flu drug. The government estimates a supply that large could treat about 5 percent of the population. The administration made the decision at a Cabinet meeting that also cemented plans to establish a task force of several ministries to prevent an outbreak of bird flu. The plans were adopted in the wake of the country's first case of the avian influenza in April. (Click here for more
You may also be interested in...
No device-related warning letters were released by the US FDA the week of 24 November.
Mooted some time ago, the Medicare Part D Drug Rebate Rule and the Medicare Part B Most-Favored-Nation Model have now been finalized by US President Donald Trump. But US off-patent body the Association for Accessible Medicines feels “further action is necessary.”
Lannett will launch a further seven products in fiscal 2021, after launching four products recently in the first quarter of FY21. The company also plans to pay off its Term Loan ‘A’ in full, by the end of November 2020.